Literature DB >> 2089172

Thrombocytopenia subsequently develops systemic lupus erythematosus--can anti-SS-A antibody predict the next event?

M Adachi1, S Mita, M Obana, Y Matsuoka, K Harada, S Irimajiri.   

Abstract

In order to detect diagnostic clues to identify patients with chronic immune thrombocytopenia which is likely to develop systemic lupus erythematosus (SLE), a retrospective study was conducted. Of 39 patients with chronic immune thrombocytopenia, 4 fulfilled the diagnostic criteria being between 4.5 and 14 years after the initial diagnosis of "idiopathic" thrombocytopenic purpura. The remaining 35 patients were found to be idiopathic thrombocytopenic purpura (ITP) after at least a 5-year follow-up. It was noted that in patients with SLE who had thrombocytopenia at presentation, only 4 or 5 findings of diagnostic criteria were observed. Of particular interest, all patients who developed SLE were positive for anti-SS-A antibody, in contrast none of the patients with ITP had this antibody. Furthermore, despite the few clinical manifestations, we noted lupus peritonitis in 1 patient and pulmonary hypertension in another patient. In conclusion, the anti-SS-A antibody is an excellent clue for the early detection of SLE occurring as "idiopathic" thrombocytopenic purpura.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2089172     DOI: 10.2169/internalmedicine1962.29.481

Source DB:  PubMed          Journal:  Jpn J Med        ISSN: 0021-5120


  2 in total

1.  Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura.

Authors:  Abdullah Altintas; Abdulkadir Ozel; Nilufer Okur; Nurettin Okur; Timucin Cil; Semir Pasa; Orhan Ayyildiz
Journal:  J Thromb Thrombolysis       Date:  2007-04-14       Impact factor: 2.300

2.  ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseases.

Authors:  Yuan Liu; Shiju Chen; Guomei Yang; Bin Wang; Jinying Lan; Fan Dai; Peishi Rao; Puqi Wu; Hongyan Qian; Guixiu Shi
Journal:  Lupus Sci Med       Date:  2021-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.